{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:32:46Z","timestamp":1792175566146,"version":"4.4.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Ductal carcinoma <jats:italic>in situ<\/jats:italic> (DCIS) is a preinvasive form of breast cancer with a highly variable potential of becoming invasive and affecting mortality of the patients. Due to the lack of accurate markers of disease progression, many women with detected DCIS are currently overtreated. To distinguish those DCIS cases who are likely to require therapy from those who should be left untreated, there is a need for robust and predictive biomarkers extracted from molecular or genetic profiles. We developed a supervised machine learning approach that implements multi-omics feature selection and model regularization for the identification of biomarker combinations that could be used to distinguish low-risk DCIS lesions from those with a higher likelihood of progression. To investigate the genetic heterogeneity of disease progression, we applied this approach to 40 pure DCIS and 259 invasive breast cancer (IBC) samples profiled with genome-wide transcriptomics, DNA methylation, and DNA copy number variation. Feature selection using the multi-omics Lasso-regularized algorithm identified both known genes involved in breast cancer development, as well as novel markers for early detection. Even though the gene expression-based model features led to the highest classification accuracy alone, methylation data provided a complementary source of features and improved especially the sensitivity of correctly classifying DCIS cases. We also identified a number of repeatedly misclassified DCIS cases when using either the expression or methylation markers. A small panel of 10 gene markers was able to distinguish DCIS and IBC cases with high accuracy in nested cross-validation (AU-ROC = 0.99). The marker panel was not specific to any of the established breast cancer subtypes, suggesting that the 10-gene signature may provide a subtype-agnostic and cost-effective approach for breast cancer detection and patient stratification. We further confirmed high accuracy of the 10-gene signature in an external validation cohort (AU-ROC = 0.95), profiled using distinct transcriptomic assay, hence demonstrating robustness of the risk signature.<\/jats:p>","DOI":"10.3389\/fgene.2021.670749","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T21:08:35Z","timestamp":1622754515000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Multi-Omics Marker Analysis Enables Early Prediction of Breast Tumor Progression"],"prefix":"10.3389","volume":"12","author":[{"given":"Haifeng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonje","family":"Lien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Bergholtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lounes","family":"Djerroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Vincent-Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"S\u00f8rlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tero","family":"Aittokallio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1158\/0008-5472.CAN-15-0506","article-title":"A molecular portrait of high-grade ductal carcinoma in situ.","volume":"75","author":"Abba","year":"2015","journal-title":"Cancer Res."},{"key":"B2","first-page":"721","article-title":"Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.","volume":"152","author":"Ahmad","year":"1998","journal-title":"Am. J. Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"6562","DOI":"10.1073\/pnas.102102699","article-title":"Selection bias in gene extraction on the basis of microarray gene-expression data.","volume":"99","author":"Ambroise","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-529","article-title":"Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo.","volume":"11","author":"Anastassiou","year":"2011","journal-title":"BMC Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-017-0812-y","article-title":"Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.","volume":"19","author":"Aure","year":"2017","journal-title":"Breast Cancer Res."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17090-y","article-title":"Predicting and affecting response to cancer therapy based on pathway-level biomarkers.","volume":"11","author":"Ben-Hamo","year":"2020","journal-title":"Nat. Commun."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-020-0167-x","article-title":"Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions.","volume":"6","author":"Bergholtz","year":"2020","journal-title":"npj Breast Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","article-title":"Long noncoding RNA and cancer: a new paradigm.","volume":"77","author":"Bhan","year":"2017","journal-title":"Cancer Res."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/cells8091015","article-title":"Long non-coding RNA in the pathogenesis of cancers.","volume":"8","author":"Chi","year":"2019","journal-title":"Cells"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/cncr.20979","article-title":"Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the nurses\u2019 health study.","volume":"103","author":"Collins","year":"2005","journal-title":"Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.molonc.2013.07.005","article-title":"Progression from ductal carcinoma in situ to invasive breast cancer: revisited.","volume":"7","author":"Cowell","year":"2013","journal-title":"Mol. Oncol."},{"key":"B12","first-page":"93","article-title":"Distribution of myofibroblast cells and microvessels around invasive ductal carcinoma of the breast and comparing with the adjacent range of their normal-to-DCIS zones.","volume":"16","author":"Dabiri","year":"2013","journal-title":"Arch. Iran. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3324\/haematol.2016.163022","article-title":"Epigenetically induced ectopic expression of uncx impairs the proliferation and differentiation of myeloid cells.","volume":"102","author":"Daniele","year":"2017","journal-title":"Haematologica"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1016\/S1470-2045(13)70598-9","article-title":"Addressing overdiagnosis and overtreatment in cancer: a prescription for change.","volume":"15","author":"Esserman","year":"2014","journal-title":"Lancet Oncol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/PREACCEPT-2333349012841587","article-title":"Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.","volume":"15","author":"Fleischer","year":"2014","journal-title":"Genome Biol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00510-x","article-title":"DNA methylation at enhancers identifies distinct breast cancer lineages.","volume":"8","author":"Fleischer","year":"2017","journal-title":"Nat. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent.","volume":"33","author":"Friedman","year":"2010","journal-title":"J. Stat. Softw."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00248","article-title":"Ductal carcinoma in Situ biology, biomarkers, and diagnosis.","volume":"7","author":"Gorringe","year":"2017","journal-title":"Front. Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1093\/bioinformatics\/btv153","article-title":"PRROC: computing and visualizing Precision-recall and receiver operating characteristic curves in R.","volume":"31","author":"Grau","year":"2015","journal-title":"Bioinformatics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.breast.2016.09.001","article-title":"Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).","volume":"31","author":"Groen","year":"2017","journal-title":"Breast"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1613","article-title":"Classification of ductal carcinoma in situ by gene expression profiling.","volume":"8","author":"Hannemann","year":"2006","journal-title":"Breast Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1158\/1538-7445.am2016-709","article-title":"Abstract 709: in vitro functional study of novel oncogene serine protease 33 (PRSS33) and the clinical significance of PRSS33 expression in colorectal cancer patients.","volume":"76","author":"Jeong","year":"2016","journal-title":"Cancer Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building predictive models in R using the caret package.","volume":"28","author":"Kuhn","year":"2008","journal-title":"J. Stat. Softw."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12883","article-title":"MAM domain containing 2 is a potential breast cancer biomarker that exhibits tumour-suppressive activity.","volume":"53","author":"Lee","year":"2020","journal-title":"Cell Prolif."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.celrep.2016.06.051","article-title":"Molecular features of subtype-specific progression from ductal carcinoma in situ to invasive breast cancer.","volume":"16","author":"Lesurf","year":"2016","journal-title":"Cell Rep."},{"key":"B26","first-page":"18","article-title":"Classification and Regression by randomForest.","volume":"2","author":"Liaw","year":"2002","journal-title":"R News"},{"key":"B27","first-page":"211","article-title":"Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target.","volume":"25","author":"Liu","year":"2018","journal-title":"Discov. Med."},{"key":"B28","first-page":"1","article-title":"Analyzing RNA-seq data with DESeq2.","volume":"2","author":"Love","year":"2017","journal-title":"Bioconductor"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1073\/pnas.0931261100","article-title":"Gene expression profiles of human breast cancer progression.","volume":"100","author":"Ma","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.01016","article-title":"Pathway-based drug response prediction using similarity identification in gene expression.","volume":"11","author":"Madani Tonekaboni","year":"2020","journal-title":"Front. Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1007\/s00018-007-7388-0","article-title":"Molecular basis of invasion in breast cancer.","volume":"64","author":"McSherry","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"B32","author":"Meyer","year":"2019","journal-title":"Package \u2018e1071\u2019: Misc Functions of the Department of Statistics, Probability Theory Group (Formerly: E1071), TU Wien. R Package version"},{"key":"B33","doi-asserted-by":"publisher","first-page":"6347","DOI":"10.1038\/onc.2008.218","article-title":"Matrix metalloproteinase-11\/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions.","volume":"27","author":"Motrescu","year":"2008","journal-title":"Oncogene"},{"key":"B34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.molonc.2010.06.007","article-title":"Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.","volume":"4","author":"Muggerud","year":"2010","journal-title":"Mol. Oncol."},{"key":"B35","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/1097-0142(1984)54:4<612::AID-CNCR2820540403>3.0.CO;2-B","article-title":"Precancerous and cancerous breast lesions during lifetime and at autopsy. A study of 83 women.","volume":"54","author":"Nielsen","year":"1984","journal-title":"Cancer"},{"key":"B36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejca.2017.04.013","article-title":"The diagnostic challenge of low-grade ductal carcinoma in situ.","volume":"80","author":"Onega","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"B37","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0","article-title":"Continued local recurrence of carcinoma 15\u201325 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy.","volume":"76","author":"Page","year":"1995","journal-title":"Cancer"},{"key":"B38","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/1097-0142(19820215)49:4<751::AID-CNCR2820490426>3.0.CO;2-Y","article-title":"Intraductal carcinoma of the breast: follow-up after biopsy only.","volume":"49","author":"Page","year":"1982","journal-title":"Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"27820","DOI":"10.1074\/jbc.M304436200","article-title":"Identification of peptide substrates for human MMP-11 (stromelysin-3) using phage display.","volume":"278","author":"Pan","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/modpathol.2017.21","article-title":"Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer.","volume":"30","author":"Pang","year":"2017","journal-title":"Mod. Pathol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes.","volume":"27","author":"Parker","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves.","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"B43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.","volume":"26","author":"Robinson","year":"2009","journal-title":"Bioinformatics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1002\/cncr.21069","article-title":"The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.","volume":"103","author":"Sanders","year":"2005","journal-title":"Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.3747\/co.25.3770","article-title":"Screening for breast cancer in 2018\u2014what should we be doing today?","volume":"25","author":"Seely","year":"2018","journal-title":"Curr. Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/jnci\/djt067","article-title":"A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.","volume":"105","author":"Solin","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s41416-020-0797-7","article-title":"The prognostic significance of immune microenvironment in breast ductal carcinoma in situ.","volume":"122","author":"Toss","year":"2020","journal-title":"Br. J. Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2217\/epi.12.21","article-title":"Complete pipeline for Infinium\u00ae Human Methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation.","volume":"4","author":"Touleimat","year":"2012","journal-title":"Epigenomics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","article-title":"Ductal carcinoma in situ: to treat or not to treat, that is the question.","volume":"121","author":"van Seijen","year":"2019","journal-title":"Br. J. Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-7-91","article-title":"Bias in error estimation when using cross-validation for model selection.","volume":"7","author":"Varma","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1158\/1078-0432.CCR-07-1465","article-title":"Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.","volume":"14","author":"Vincent-Salomon","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/jnci\/djp482","article-title":"Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.","volume":"102","author":"Virnig","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1038\/bjc.2012.151","article-title":"The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS.","volume":"106","author":"Wallis","year":"2012","journal-title":"Br. J. Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.50","article-title":"PAK1 regulates RUFY3-mediated gastric cancer cell migration and invasion.","volume":"6","author":"Wang","year":"2015","journal-title":"Cell Death Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.2147\/OTT.S160831","article-title":"MFAP2 promotes epithelial\u2013mesenchymal transition in gastric cancer cells by activating TGF-\u03b2\/SMAD2\/3 signaling pathway.","volume":"11","author":"Wang","year":"2018","journal-title":"Onco Targets Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-011-1387-4","article-title":"Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.","volume":"127","author":"Wang","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20193286","article-title":"Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.","volume":"40","author":"Zhang","year":"2020","journal-title":"Biosci. Rep."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.597569","article-title":"Identification and validation of an autophagy-related lncRNA signature for patients with breast cancer.","volume":"10","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.3892\/ijo.2016.3400","article-title":"Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review).","volume":"48","author":"Zhang","year":"2016","journal-title":"Int. J. Oncol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.670749\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T21:08:45Z","timestamp":1622754525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.670749\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":59,"alternative-id":["10.3389\/fgene.2021.670749"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2021.670749","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,3]]},"article-number":"670749"}}